Effects of the Length of Stay on the Cost of Total Knee and Total Hip Arthroplasty from 2002 to 2013
- PMID: 28244911
- PMCID: PMC5324037
- DOI: 10.2106/JBJS.16.00019
Effects of the Length of Stay on the Cost of Total Knee and Total Hip Arthroplasty from 2002 to 2013
Abstract
Background: Utilization of total knee and hip arthroplasty has greatly increased in the past decade in the United States; these are among the most expensive procedures in patients with Medicare. Advances in surgical techniques, anesthesia, and care pathways decrease hospital length of stay. We examined how trends in hospital cost were altered by decreases in length of stay.
Methods: Procedure, demographic, and economic data were collected on 6.4 million admissions for total knee arthroplasty and 2.8 million admissions for total hip arthroplasty from 2002 to 2013 using the National (Nationwide) Inpatient Sample, a component of the Healthcare Cost and Utilization Project. Trends in mean hospital costs and their association with length of stay were estimated using inflation-adjusted, survey-weighted generalized linear regression models, controlling for patient demographic characteristics and comorbidity.
Results: From 2002 to 2013, the length of stay decreased from a mean time of 4.06 to 2.97 days for total knee arthroplasty and from 4.06 to 2.75 days for total hip arthroplasty. During the same time period, the mean hospital cost for total knee arthroplasty increased from $14,988 (95% confidence interval [CI], $14,927 to $15,049) in 2002 to $22,837 (95% CI, $22,765 to $22,910) in 2013 (an overall increase of $7,849 or 52.4%). The mean hospital cost for total hip arthroplasty increased from $15,792 (95% CI, $15,706 to $15,878) in 2002 to $23,650 (95% CI, $23,544 to $23,755) in 2013 (an increase of $7,858 or 49.8%). If length of stay were set at the 2002 mean, the growth in cost for total knee arthroplasty would have been 70.8% instead of 52.4% as observed, and the growth in cost for total hip arthroplasty would have been 67.4% instead of 49.8% as observed.
Conclusions: Hospital costs for joint replacement increased from 2002 to 2013, but were attenuated by reducing inpatient length of stay. With demographic characteristics showing an upward trend in the utilization of joint arthroplasty, including a shift toward younger population groups, reduction in length of stay remains an important target for procedure-level cost containment under emerging payment models.
Figures

Similar articles
-
Which Clinical and Patient Factors Influence the National Economic Burden of Hospital Readmissions After Total Joint Arthroplasty?Clin Orthop Relat Res. 2017 Dec;475(12):2926-2937. doi: 10.1007/s11999-017-5244-6. Clin Orthop Relat Res. 2017. PMID: 28108823 Free PMC article.
-
The Role of Overweight and Obesity in Relation to the More Rapid Growth of Total Knee Arthroplasty Volume Compared with Total Hip Arthroplasty Volume.J Bone Joint Surg Am. 2014 Jun 4;96(11):922-928. doi: 10.2106/JBJS.L.01731. Epub 2014 Jun 4. J Bone Joint Surg Am. 2014. PMID: 24897740
-
Are Bundled Payments a Viable Reimbursement Model for Revision Total Joint Arthroplasty?Clin Orthop Relat Res. 2016 Dec;474(12):2714-2721. doi: 10.1007/s11999-016-4953-6. Epub 2016 Jun 29. Clin Orthop Relat Res. 2016. PMID: 27357691 Free PMC article.
-
Bundle Payment for Musculoskeletal Care: Current Evidence (Part 1).Orthop Clin North Am. 2018 Apr;49(2):135-146. doi: 10.1016/j.ocl.2017.11.002. Epub 2017 Dec 22. Orthop Clin North Am. 2018. PMID: 29499815 Review.
-
Bundle Payment for Musculoskeletal Care: Current Evidence (Part 2).Orthop Clin North Am. 2018 Apr;49(2):147-156. doi: 10.1016/j.ocl.2017.11.003. Epub 2018 Feb 3. Orthop Clin North Am. 2018. PMID: 29499816 Review.
Cited by
-
An injectable self-adaptive polymer as a drug carrier for the treatment of nontraumatic early-stage osteonecrosis of the femoral head.Bone Res. 2022 Mar 12;10(1):28. doi: 10.1038/s41413-022-00196-y. Bone Res. 2022. PMID: 35279673 Free PMC article.
-
Surgical resection for suppurative thrombophlebitis of the great saphenous vein after radiofrequency ablation.J Vasc Surg Cases Innov Tech. 2019 Nov 22;5(4):532-534. doi: 10.1016/j.jvscit.2019.06.005. eCollection 2019 Dec. J Vasc Surg Cases Innov Tech. 2019. PMID: 31799481 Free PMC article.
-
The Impact of Morbid Obesity on In-hospital Outcomes after Revision Total Hip Arthroplasty: An Analysis of the National Inpatient Sample.J Am Acad Orthop Surg Glob Res Rev. 2022 Aug 5;6(8):e22.00023. doi: 10.5435/JAAOSGlobal-D-22-00023. eCollection 2022 Aug 1. J Am Acad Orthop Surg Glob Res Rev. 2022. PMID: 35944109 Free PMC article.
-
The Impact of Discharge Timing on Readmission Following Hepatopancreatobiliary Surgery: a Nationwide Readmission Database Analysis.J Gastrointest Surg. 2018 Sep;22(9):1538-1548. doi: 10.1007/s11605-018-3783-0. Epub 2018 May 7. J Gastrointest Surg. 2018. PMID: 29736663
-
Length of stay and inpatient charges of total knee arthroplasty in China: analysis of a national database.Chin Med J (Engl). 2023 Sep 5;136(17):2050-2057. doi: 10.1097/CM9.0000000000002220. Chin Med J (Engl). 2023. PMID: 37218077 Free PMC article.
References
-
- Centers for Disease Control and Prevention/National Center for Health Statistics. National Hospital Discharge Survey. 2015 Sep 2. http://www.cdc.gov/nchs/nhds/. Accessed 2016 Sep 8.
-
- Kim SH. Morbid obesity and excessive hospital resource consumption for unilateral primary hip and knee arthroplasty. J Arthroplasty. 2010. December;25(8):1258-66. Epub 2009 Oct 30. - PubMed
-
- Belatti DA, Pugely AJ, Phisitkul P, Amendola A, Callaghan JJ. Total joint arthroplasty: trends in Medicare reimbursement and implant prices. J Arthroplasty. 2014. August;29(8):1539-44. Epub 2014 Mar 22. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous